Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2018
Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter studyMihoko Nakamura, Tsutomu Takahashi, Yoichiro Takayanagi, et al.
Biological Psychiatry|July 16, 2017
Increased Occipital Gyrification and Development of Psychotic Disorders in Individuals With an At-Risk Mental State: A Multicenter StudyDaiki Sasabayashi, Yoichiro Takayanagi, Tsutomu Takahashi, et al.
Frontiers in Psychiatry|December 17, 2020
Structural MRI Study of the Planum Temporale in Individuals With an At-Risk Mental State Using Labeled Cortical Distance MappingYoichiro Takayanagi, Sue Kulason, Daiki Sasabayashi, et al.
Schizophrenia Bulletin|March 13, 2020
Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental StateDaiki Sasabayashi, Yoichiro Takayanagi, Tsutomu Takahashi, et al.
Psychiatry and Clinical Neurosciences|September 27, 2022
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophreniaKazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, et al.
Schizophrenia Bulletin|June 25, 2025
Saturated Fatty Acids and White Matter Microstructure in Individuals With At-risk Mental StateDaiki Sasabayashi, Hiroko Itoh, Kiyotaka Nemoto, et al.
Translational Psychiatry|July 20, 2021
Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomesDaiki Sasabayashi, Yoichiro Takayanagi, Tsutomu Takahashi, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Frontiers in Pharmacology|October 31, 2022
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's diseaseMosaburo Kainuma, Shinji Ouma, Shinobu Kawakatsu, et al.
Pageof 8